SILSC stands for

SILSC GmbH - Life Science Consultancy

Schönfeld

Ivezić

Life

Science

Consulting

The consultancy company founded by Wolfgang Schönfeld and Zrinka Ivezić Schönfeld

Our know-how is built on:

  • Long-standing international management in Pharma & Biotech industry with emphasis on R&D, regulatory affairs, intellectual property und strategy

  • Extensive know-how and experience with variety of drug candidates and approved pharmaceuticals (small molecules, biologics), nutraceuticals, medical devices and across various indications (emphasis on anti-infectives, oncology, aesthetic dermatology)

  • Experience as members of various executive management bodies and advisory boards

  • Experience in company management in CEO, VP, and managing director roles

  • Expertise in company set-up, building-up several companies from the scratch

  • Proficiency in the set-up of project organizations and departments in several companies

  • Inter-disciplinary engagement in a multi-national environment

  • Succesfully bringing projects from research concepts and preclinical activities through clinical phases 1-3 and post-marketing studies

SILSC GmbH - Kunde

We utilize an independent, analytical, and structured working style with a keen perception and strong sense of responsibility.

 

Consulting is possible in three languages:
English, German, Croatian.

SILSC GmbH TEAM

SILSC GmbH - Wolfgang Schönfeld

Wolfgang Schoenfeld, MD
PARTNER & MANAGING DIRECTOR

Wolfgang is senior manager/executive with 30+ years of experience in biotechnology and pharmaceutical industry; entrepreneur with various CEO positions in biotech industry; covering basic research, successful preclinical and clinical development of novel pharmaceuticals (including phase 2), development and marketing of unique proprietary nutraceuticals.

SILSC GmbH - ZRINKA IVEZIC SCHOENFELD

Zrinka Ivezic Schoenfeld, PHD
PARTNER & MANAGING DIRECTOR

Zrinka is senior manager/executive with 25+ years of experience in biotechnology and pharmaceutical industry, building and leading multidisciplinary international drug discovery and development projects, teams, and departments from early research and pre-clinical activities through all phases of clinical trials and post-marketing studies in the field of pharmaceuticals and medical devices.